{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:00:35Z","timestamp":1790172035130,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"40","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,10,20]]},"DOI":"10.1038\/s41388-026-03942-2","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:27:21Z","timestamp":1786552041000},"page":"4254-4268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the SELP\/PSGL1 axis reprograms M2 macrophages and enhances anti-PD-1 efficacy in gastric cancer"],"prefix":"10.1038","volume":"45","author":[{"given":"Yue","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3718-466X","authenticated-orcid":false,"given":"Xianbao","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"3942_CR1","unstructured":"Menon G, El-Nakeep S, Babiker HM. Gastric cancer. StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2025."},{"key":"3942_CR2","unstructured":"Parikh NS, Ahlawat R. Helicobacter Pylori. StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2025."},{"key":"3942_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1053\/j.gastro.2023.04.026","volume":"165","author":"D Li","year":"2023","unstructured":"Li D, Jiang SF, Lei NY, Shah SC, Corley DA. Effect of Helicobacter pylori eradication therapy on the incidence of noncardia gastric adenocarcinoma in a large diverse population in the United States. Gastroenterology. 2023;165:391\u2013401.e2.","journal-title":"Gastroenterology"},{"key":"3942_CR4","unstructured":"Marsh AM, Buicko Lopez JL. Gastric resection for malignancy (gastrectomy). StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2025."},{"key":"3942_CR5","doi-asserted-by":"publisher","first-page":"e006454.","DOI":"10.1136\/jitc-2022-006454","volume":"11","author":"J Jung","year":"2023","unstructured":"Jung J, Heo YJ, Park S. High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis. J Immunother Cancer. 2023;11:e006454.","journal-title":"J Immunother Cancer"},{"key":"3942_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.5230\/jgc.2023.23.e17","volume":"23","author":"C Wang","year":"2023","unstructured":"Wang C, Wang Z, Zhao Y, Wang F. Neoadjuvant PD-1 inhibitor plus apatinib and chemotherapy versus apatinib plus chemotherapy in treating patients with locally advanced gastric cancer: a prospective, cohort study. J Gastric Cancer. 2023;23:328\u201339.","journal-title":"J Gastric Cancer"},{"key":"3942_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.semcancer.2023.04.009","volume":"93","author":"Z Wang","year":"2023","unstructured":"Wang Z, Liu Y, Niu X. Application of artificial intelligence for improving early detection and prediction of therapeutic outcomes for gastric cancer in the era of precision oncology. Semin Cancer Biol. 2023;93:83\u201396.","journal-title":"Semin Cancer Biol"},{"key":"3942_CR8","doi-asserted-by":"publisher","first-page":"951.","DOI":"10.3390\/ph17070951","volume":"17","author":"X Pei","year":"2024","unstructured":"Pei X, Zhang SL, Qiu BQ, Zhang PF, Liu TS, Wang Y. Cancer cell secreted legumain promotes gastric cancer resistance to anti-PD-1 immunotherapy by enhancing macrophage M2 polarization. Pharmaceuticals. 2024;17:951.","journal-title":"Pharmaceuticals"},{"key":"3942_CR9","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s12013-024-01562-9","volume":"83","author":"X Xu","year":"2025","unstructured":"Xu X, Xu Z, Cai Y, Chen X, Huang C. CKIP-1 inhibits M2 macrophage polarization to suppress the progression of gastric cancer by inactivating JAK\/STAT3 signaling. Cell Biochem Biophys. 2025;83:1289\u201398.","journal-title":"Cell Biochem Biophys"},{"key":"3942_CR10","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s12010-024-05073-4","volume":"197","author":"X Yang","year":"2025","unstructured":"Yang X, Qi Y, Wang S. DKN-01 suppresses gastric cancer progression through activating cGAS-STING pathway to block macrophage M2 polarization. Appl Biochem Biotechnol. 2025;197:1025\u201338.","journal-title":"Appl Biochem Biotechnol"},{"key":"3942_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156137","volume":"135","author":"J Yi","year":"2024","unstructured":"Yi J, Ye Z, Xu H, Zhang H, Cao H, Li X, et al. EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p. Phytomedicine. 2024;135:156137.","journal-title":"Phytomedicine"},{"key":"3942_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109217","volume":"112","author":"X Chen","year":"2022","unstructured":"Chen X, Jiang J, Liu H, Li A, Wang W, Ni Z, et al. MSR1 characterized by chromatin accessibility mediates M2 macrophage polarization to promote gastric cancer progression. Int Immunopharmacol. 2022;112:109217.","journal-title":"Int Immunopharmacol"},{"key":"3942_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156750","volume":"141","author":"X Tu","year":"2025","unstructured":"Tu X, Lin W, Zhai X, Liang S, Huang G, Wang J, et al. Oleanolic acid inhibits M2 macrophage polarization and potentiates anti-PD-1 therapy in hepatocellular carcinoma by targeting miR-130b-3p-PTEN-PI3K-Akt signaling and glycolysis. Phytomedicine. 2025;141:156750.","journal-title":"Phytomedicine"},{"key":"3942_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109636","volume":"121","author":"H Zhuang","year":"2020","unstructured":"Zhuang H, Dai X, Zhang X, Mao Z, Huang H. Sophoridine suppresses macrophage-mediated immunosuppression through TLR4\/IRF3 pathway and subsequently upregulates CD8(+) T cytotoxic function against gastric cancer. Biomed Pharmacother. 2020;121:109636.","journal-title":"Biomed Pharmacother"},{"key":"3942_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02244-7","volume":"24","author":"Q Huang","year":"2025","unstructured":"Huang Q, Yang W, Wang F, Huang R, Wang Q, Li X, et al. SELP(+) TEC:CD8(+) T cell crosstalk associates with improved radiotherapy efficacy in cervical cancer. Mol Cancer. 2025;24:41.","journal-title":"Mol Cancer"},{"key":"3942_CR16","doi-asserted-by":"publisher","first-page":"e103872","DOI":"10.1371\/journal.pone.0103872","volume":"9","author":"J Burkhardt","year":"2014","unstructured":"Burkhardt J, Blume M, Petit-Teixeira E, Hugo Teixeira V, Steiner A, Quente E, et al. Cellular adhesion gene SELP is associated with rheumatoid arthritis and displays differential allelic expression. PLoS ONE. 2014;9:e103872.","journal-title":"PLoS ONE"},{"key":"3942_CR17","doi-asserted-by":"publisher","first-page":"855.","DOI":"10.3390\/cells9040855","volume":"9","author":"D Stoiber","year":"2020","unstructured":"Stoiber D, Assinger A. Platelet-leukocyte interplay in cancer development and progression. Cells. 2020;9:855.","journal-title":"Cells"},{"key":"3942_CR18","doi-asserted-by":"publisher","first-page":"e108057","DOI":"10.1371\/journal.pone.0108057","volume":"9","author":"A Avan","year":"2014","unstructured":"Avan A, Avan A, Le Large TY, Mambrini A, Funel N, Maftouh M, et al. AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients. PLoS ONE. 2014;9:e108057.","journal-title":"PLoS ONE"},{"key":"3942_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adn4302","volume":"10","author":"C Zhong","year":"2025","unstructured":"Zhong C, Wang L, Liu Y, Wang X, Xia Z, Li Y, et al. PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance. Sci Immunol. 2025;10:eadn4302.","journal-title":"Sci Immunol"},{"key":"3942_CR20","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1158\/2767-9764.CRC-22-0513","volume":"3","author":"K Kauffman","year":"2023","unstructured":"Kauffman K, Manfra D, Nowakowska D, Zafari M, Nguyen PA, Phennicie R, et al. PSGL-1 blockade induces classical activation of human tumor-associated macrophages. Cancer Res Commun. 2023;3:2182\u201394.","journal-title":"Cancer Res Commun"},{"key":"3942_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112436","volume":"42","author":"JL Hope","year":"2023","unstructured":"Hope JL, Otero DC, Bae EA, Stairiker CJ, Palete AB, Faso HA, et al. PSGL-1 attenuates early TCR signaling to suppress CD8(+) T cell progenitor differentiation and elicit terminal CD8(+) T cell exhaustion. Cell Rep. 2023;42:112436.","journal-title":"Cell Rep"},{"key":"3942_CR22","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s12672-025-02629-6","volume":"16","author":"Y Wu","year":"2025","unstructured":"Wu Y, Liu J, Yin T, Li X, Liu X, Peng X, et al. SELP can affect the immune microenvironment of gastric cancer and is associated with poor prognosis. Discov Oncol. 2025;16:846.","journal-title":"Discov Oncol"},{"key":"3942_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1158\/1541-7786.MCR-16-0309","volume":"15","author":"J Li","year":"2017","unstructured":"Li J, Zhou Z, Zhang X, Zheng L, He D, Ye Y, et al. Inflammatory molecule, PSGL-1, deficiency activates macrophages to promote colorectal cancer growth through NF\u03baB signaling. Mol Cancer Res. 2017;15:467\u201377.","journal-title":"Mol Cancer Res"},{"key":"3942_CR24","first-page":"5399","volume":"18","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Fang YC, Li J. PD-L1 expression levels on tumor cells affect their immunosuppressive activity. Oncol Lett. 2019;18:5399\u2013407.","journal-title":"Oncol Lett"},{"key":"3942_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2015.12.042","volume":"164","author":"H Hu","year":"2016","unstructured":"Hu H, Juvekar A, Lyssiotis CA, Lien EC, Albeck JG, Oh D, et al. Phosphoinositide 3-kinase regulates glycolysis through mobilization of aldolase from the actin cytoskeleton. Cell. 2016;164:433\u201346.","journal-title":"Cell"},{"key":"3942_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02998-6","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, et al. PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis. 2020;11:797.","journal-title":"Cell Death Dis"},{"key":"3942_CR27","doi-asserted-by":"publisher","first-page":"e176851.","DOI":"10.1172\/JCI176851","volume":"134","author":"S Wang","year":"2024","unstructured":"Wang S, Huang T, Wu Q, Yuan H, Wu X, Yuan F. Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation. J Clin Invest. 2024;134:e176851.","journal-title":"J Clin Invest"},{"key":"3942_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1386","volume":"13","author":"J Li","year":"2023","unstructured":"Li J, Sun J, Zeng Z, Liu Z, Ma M, Zheng Z, et al. Tumour-associated macrophages in gastric cancer: From function and mechanism to application. Clin Transl Med. 2023;13:e1386.","journal-title":"Clin Transl Med"},{"key":"3942_CR29","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1111\/cas.14616","volume":"111","author":"Q Luo","year":"2020","unstructured":"Luo Q, Zheng N, Jiang L, Wang T, Zhang P, Liu Y, et al. Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer. Cancer Sci. 2020;111:4000\u201311.","journal-title":"Cancer Sci"},{"key":"3942_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbrc.2022.12.076","volume":"646","author":"F He","year":"2023","unstructured":"He F, Chen Y, He D, He S. USP14-mediated deubiquitination of SIRT1 in macrophage promotes fatty acid oxidation amplification and M2 phenotype polarization. Biochem Biophys Res Commun. 2023;646:19\u201329.","journal-title":"Biochem Biophys Res Commun"},{"key":"3942_CR31","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cmet.2018.03.008","volume":"27","author":"GA Brooks","year":"2018","unstructured":"Brooks GA. The science and translation of lactate shuttle theory. Cell Metab. 2018;27:757\u201385.","journal-title":"Cell Metab"},{"key":"3942_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"3942_CR33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/cvr\/cvq050","volume":"86","author":"S Hortelano","year":"2010","unstructured":"Hortelano S, L\u00f3pez-Fontal R, Trav\u00e9s PG, Villa N, Grashoff C, Bosc\u00e1 L, et al. ILK mediates LPS-induced vascular adhesion receptor expression and subsequent leucocyte trans-endothelial migration. Cardiovasc Res. 2010;86:283\u201392.","journal-title":"Cardiovasc Res"},{"key":"3942_CR34","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1083\/jcb.200612053","volume":"178","author":"JD van Buul","year":"2007","unstructured":"van Buul JD, Allingham MJ, Samson T, Meller J, Boulter E, Garc\u00eda-Mata R, et al. RhoG regulates endothelial apical cup assembly downstream from ICAM1 engagement and is involved in leukocyte trans-endothelial migration. J Cell Biol. 2007;178:1279\u201393.","journal-title":"J Cell Biol"},{"key":"3942_CR35","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1096\/fj.201700280R","volume":"31","author":"M Yan","year":"2017","unstructured":"Yan M, Zhang X, Chen A, Gu W, Liu J, Ren X, et al. Endothelial cell SHP-2 negatively regulates neutrophil adhesion and promotes transmigration by enhancing ICAM-1-VE-cadherin interaction. FASEB J. 2017;31:4759\u201369.","journal-title":"FASEB J"},{"key":"3942_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22186-0","volume":"12","author":"E Yeini","year":"2021","unstructured":"Yeini E, Ofek P, Pozzi S, Albeck N, Ben-Shushan D, Tiram G, et al. P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression. Nat Commun. 2021;12:1912.","journal-title":"Nat Commun"},{"key":"3942_CR37","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/leu.2012.272","volume":"27","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, Yang J, Qian J, Qiu P, Hanabuchi S, Lu Y, et al. PSGL-1\/selectin and ICAM-1\/CD18 interactions are involved in macrophage-induced drug resistance in myeloma. Leukemia. 2013;27:702\u201310.","journal-title":"Leukemia"},{"key":"3942_CR38","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.7150\/thno.80555","volume":"13","author":"X Li","year":"2023","unstructured":"Li X, Chen X, Gong S, Zhao J, Yao C, Zhu H, et al. Platelets promote CRC by activating the C5a\/C5aR1 axis via PSGL-1\/JNK\/STAT1 signaling in tumor-associated macrophages. Theranostics. 2023;13:2040\u201356.","journal-title":"Theranostics"},{"key":"3942_CR39","doi-asserted-by":"publisher","first-page":"2778.","DOI":"10.3390\/cancers16162778","volume":"16","author":"T Novobrantseva","year":"2024","unstructured":"Novobrantseva T, Manfra D, Ritter J, Razlog M, O\u2019Nuallain B, Zafari M, et al. Preclinical Efficacy of VTX-0811: a humanized first-in-class PSGL-1 mAb targeting TAMs to suppress tumor growth. Cancers. 2024;16:2778.","journal-title":"Cancers"},{"key":"3942_CR40","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3389\/fimmu.2019.01321","volume":"10","author":"HA Watson","year":"2019","unstructured":"Watson HA, Durairaj RRP, Ohme J, Alatsatianos M, Almutairi H, Mohammed RN, et al. L-selectin enhanced T cells improve the efficacy of cancer immunotherapy. Front Immunol. 2019;10:1321.","journal-title":"Front Immunol"},{"key":"3942_CR41","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/glycob\/cwx105","volume":"28","author":"L Borsig","year":"2018","unstructured":"Borsig L. Selectins in cancer immunity. Glycobiology. 2018;28:648\u201355.","journal-title":"Glycobiology"},{"key":"3942_CR42","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.7150\/ijbs.89942","volume":"20","author":"F Fontana","year":"2024","unstructured":"Fontana F, Giannitti G, Marchesi S, Limonta P. The PI3K\/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer. Int J Biol Sci. 2024;20:3113\u201325.","journal-title":"Int J Biol Sci"},{"key":"3942_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04632-z","volume":"13","author":"H Jiang","year":"2022","unstructured":"Jiang H, Wei H, Wang H, Wang Z, Li J, Ou Y, et al. Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer. Cell Death Dis. 2022;13:206.","journal-title":"Cell Death Dis"},{"key":"3942_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.abb2683","volume":"371","author":"K Xu","year":"2021","unstructured":"Xu K, Yin N, Peng M, Stamatiades EG, Shyu A, Li P, et al. Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity. Science. 2021;371:405\u201310.","journal-title":"Science"},{"key":"3942_CR45","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semcancer.2022.11.007","volume":"87","author":"D Sharma","year":"2022","unstructured":"Sharma D, Singh M, Rani R. Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics. Semin Cancer Biol. 2022;87:184\u201395.","journal-title":"Semin Cancer Biol"},{"key":"3942_CR46","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim ST, Cristescu R, Bass AJ, Kim KM, Odegaard JI, Kim K, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24:1449\u201358.","journal-title":"Nat Med"},{"key":"3942_CR47","doi-asserted-by":"publisher","first-page":"e180013","DOI":"10.1001\/jamaoncol.2018.0013","volume":"4","author":"CS Fuchs","year":"2018","unstructured":"Fuchs CS, Doi T, Jang RW, Muro K, Satoh T, Machado M, et al. Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE-059 Trial. JAMA Oncol. 2018;4:e180013.","journal-title":"JAMA Oncol"},{"key":"3942_CR48","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","volume":"390","author":"YK Kang","year":"2017","unstructured":"Kang YK, Boku N, Satoh T, Ryu MH, Chao Y, Kato K, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390:2461\u201371.","journal-title":"Lancet"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03942-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03942-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03942-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:09:57Z","timestamp":1790168997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03942-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":48,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2026,10,20]]}},"alternative-id":["3942"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03942-2","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All procedures performed using human tissues were approved by the Ethics Committee of Shanghai Changhai Hospital (Approval No. CHEC-Y2020-036), and informed consent was obtained from all participants. All animal experimental protocols were conducted according to the Shanghai Changhai Hospital guidelines for animal research and were approved by the Ethics Committee of the Shanghai Changhai Hospital (CHEC (A.E) 2025-044).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}